Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps
Clinical trial NCT03960580 · COMPLETED
Trial details
- NCT number
- NCT03960580
- Sponsor
- Optinose US Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2022-05-04
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.